Eric Lefkofsky and Tempus Labs
Eric Lefkofsk, the co-founder of Tempus Labs, is considered one of Chicago’s most influential entrepreneurs. He has aided in the startup of companies such as Echo Global Logistics, Mediaocean, and InnerWorkings. These companies are known globally and altogether house over 11,000 employees in 48 different countries. Each company has different functions of operations ranging from advertising to global marketing, but Tempus Labs seem to stand out amongst them all.
Tempus Lab was founded in 2015 and since then has increased its net worth to approximately $700 million while raising $130 million in funding. What makes Tempus such a powerhouse is its use of genomic data inside of its clinical settings. Tempus runs complex algorithms that gather information from patients throughout history and analyze the information. The data is then collected and studied by the patient’s physician. The physician then is able to make thorough decisions about the best treatment options for the patient.
Tempus Labs have set the tone for other companies in the medical industry with its groundbreaking technologies; which are beneficial when it comes to treating all types of diseases. Gene therapy and gene editing are examples of two biotechnologies found within Tempus that are used to treat diseases that were thought untreatable. Tempus is trying to take medical treatments to the next level by using its own analysis and combining it with the information that it receives from other entities like-minded. Tempus then stores the data and through trial and error, the best treatment options for patients are chose.
Tempus is truly in the cusp of the 21st Century as it uses technology to aid in the treatment of patients. Thanks to Eric Lefkofsk’s background in marketing, Tempus has found ways to gain partners. These partners consist of physicians and hospitals and they share data with Tempus about which treatments seem to work and which ones that don’t. In return, Tempus Labs give access of its genomic sequencing with cutting-edge analytics to the physicians and hospitals so they can find better ways of treating their patients. Cancer patients are among the list of patients that have benefited from Tempus because of physicians using Tempus’s interactive analytical and machine learning platform in a way to make key, real-time decisions.
About Eric Lefkofsky: www.crunchbase.com/person/eric-lefkofsky
Tags: best treatment options